Stephen Baxter
Stock Analyst at Wells Fargo
(3.44)
# 769
Out of 4,810 analysts
167
Total ratings
45.63%
Success rate
2.55%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MCK McKesson | Maintains: Equal-Weight | $641 → $691 | $693.98 | -0.43% | 5 | Mar 14, 2025 | |
| COR Cencora | Maintains: Equal-Weight | $251 → $274 | $284.29 | -3.62% | 2 | Mar 14, 2025 | |
| OSCR Oscar Health | Downgrades: Equal-Weight | $20 → $16 | $12.42 | +28.82% | 10 | Mar 13, 2025 | |
| UHS Universal Health Services | Maintains: Overweight | $230 → $225 | $178.82 | +25.82% | 13 | Mar 10, 2025 | |
| CYH Community Health Systems | Maintains: Underweight | $2.5 → $2 | $2.58 | -22.48% | 8 | Mar 10, 2025 | |
| MOH Molina Healthcare | Upgrades: Overweight | $295 → $372 | $348.57 | +6.72% | 17 | Mar 5, 2025 | |
| CNC Centene | Maintains: Overweight | $76 → $72 | $63.01 | +14.27% | 21 | Feb 14, 2025 | |
| CVS CVS Health | Maintains: Overweight | $68 → $73 | $69.20 | +5.49% | 13 | Feb 13, 2025 | |
| CI The Cigna Group | Maintains: Equal-Weight | $370 → $341 | $329.20 | +3.58% | 6 | Feb 4, 2025 | |
| CAH Cardinal Health | Maintains: Equal-Weight | $135 → $136 | $134.78 | +0.91% | 6 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $694 → $660 | $587.06 | +12.42% | 10 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $483 → $478 | $441.17 | +8.35% | 9 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $21 | $17.10 | +22.81% | 3 | Nov 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $205 → $150 | $124.91 | +20.09% | 12 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $400 → $320 | $340.62 | -6.05% | 13 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $387 → $290 | $284.82 | +1.82% | 10 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $7.24 | +107.18% | 3 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $16 → $8 | $5.60 | +42.86% | 6 | Feb 26, 2024 |
McKesson
Mar 14, 2025
Maintains: Equal-Weight
Price Target: $641 → $691
Current: $693.98
Upside: -0.43%
Cencora
Mar 14, 2025
Maintains: Equal-Weight
Price Target: $251 → $274
Current: $284.29
Upside: -3.62%
Oscar Health
Mar 13, 2025
Downgrades: Equal-Weight
Price Target: $20 → $16
Current: $12.42
Upside: +28.82%
Universal Health Services
Mar 10, 2025
Maintains: Overweight
Price Target: $230 → $225
Current: $178.82
Upside: +25.82%
Community Health Systems
Mar 10, 2025
Maintains: Underweight
Price Target: $2.5 → $2
Current: $2.58
Upside: -22.48%
Molina Healthcare
Mar 5, 2025
Upgrades: Overweight
Price Target: $295 → $372
Current: $348.57
Upside: +6.72%
Centene
Feb 14, 2025
Maintains: Overweight
Price Target: $76 → $72
Current: $63.01
Upside: +14.27%
CVS Health
Feb 13, 2025
Maintains: Overweight
Price Target: $68 → $73
Current: $69.20
Upside: +5.49%
The Cigna Group
Feb 4, 2025
Maintains: Equal-Weight
Price Target: $370 → $341
Current: $329.20
Upside: +3.58%
Cardinal Health
Feb 4, 2025
Maintains: Equal-Weight
Price Target: $135 → $136
Current: $134.78
Upside: +0.91%
Jan 28, 2025
Maintains: Overweight
Price Target: $694 → $660
Current: $587.06
Upside: +12.42%
Jan 28, 2025
Maintains: Overweight
Price Target: $483 → $478
Current: $441.17
Upside: +8.35%
Nov 27, 2024
Maintains: Overweight
Price Target: $17 → $21
Current: $17.10
Upside: +22.81%
Nov 25, 2024
Downgrades: Equal-Weight
Price Target: $205 → $150
Current: $124.91
Upside: +20.09%
Nov 25, 2024
Downgrades: Underweight
Price Target: $400 → $320
Current: $340.62
Upside: -6.05%
Nov 4, 2024
Maintains: Overweight
Price Target: $387 → $290
Current: $284.82
Upside: +1.82%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $7.24
Upside: +107.18%
Feb 26, 2024
Maintains: Overweight
Price Target: $16 → $8
Current: $5.60
Upside: +42.86%